The objective of this study is to investigate the efficacy of implementing the AI-SaMD(VUNO MedĀ®-Fundus AIā¢) alongside routine clinical practice for the detection of diabetic retinopathy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
True Referral Rate
Timeframe: within 6 months